Ninety-day prognosis of patients receiving direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: The real life evidence

Thromb Res. 2018 Dec:172:165-168. doi: 10.1016/j.thromres.2018.11.004. Epub 2018 Nov 3.
No abstract available

Keywords: Apixaban; Dabigatran; Direct oral anticoagulants; Edoxaban; Prognosis; Rivaroxaban; Stroke.

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Brain Ischemia / complications
  • Brain Ischemia / diagnosis
  • Brain Ischemia / drug therapy*
  • Dabigatran / administration & dosage
  • Dabigatran / adverse effects
  • Dabigatran / therapeutic use
  • Female
  • Hemorrhage / chemically induced
  • Humans
  • Male
  • Prognosis
  • Pyrazoles / administration & dosage
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use
  • Pyridines / administration & dosage
  • Pyridines / adverse effects
  • Pyridines / therapeutic use
  • Pyridones / administration & dosage
  • Pyridones / adverse effects
  • Pyridones / therapeutic use
  • Rivaroxaban / administration & dosage
  • Rivaroxaban / adverse effects
  • Rivaroxaban / therapeutic use
  • Secondary Prevention
  • Thiazoles / administration & dosage
  • Thiazoles / adverse effects
  • Thiazoles / therapeutic use

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiazoles
  • apixaban
  • Rivaroxaban
  • Dabigatran
  • edoxaban